Global Diabetic Footwear Market By Product (Slippers, Sandals, Shoes) By Distribution Channel (Offline, Online) By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
- Published date: March 2024
- Report ID: 36931
- Number of Pages: 266
- Format:
- keyboard_arrow_up
Quick Navigation
Market Overview
The Global Diabetic Footwear Market size is expected to be worth around USD 18.2 Billion by 2033 from USD 8.5 Billion in 2023, growing at a CAGR of 7.9% during the forecast period from 2024 to 2033.
Diabetic footwear was specifically created to meet the needs of those living with diabetes and help minimize foot complications. Constructed for comfort, protection, and support, diabetic shoes strive to prevent foot ulcers as well as relieve nerve damage, neuropathy symptoms, or deformities associated with their disease.
Diabetic footwear has been carefully constructed to reduce the chance of foot injuries such as cuts, scrapes and blisters and ensure foot safety from external hazards. By protecting skin integrity and decreasing susceptibility to bacteria infections, diabetic footwear promotes overall foot health thereby creating an ideal environment for optimal care of feet.
Diabetes cases worldwide are projected to accelerate demand for diabetic footwear worldwide. According to data from the International Diabetes Federation, in 2019, 463 million adult diabetics existed globally with this figure expected to skyrocket by 2045 – driving market expansion further through increasing interest for athletic diabetic footwear among diabetic individuals.
Key Takeaways
- Market Size: Diabetic Footwear Market size is expected to be worth around USD 18.2 Billion by 2033 from USD 8.5 Billion in 2023.
- Market Growth: The market growing at a CAGR of 7.9% during the forecast period from 2024 to 2033.
- Product Analysis: Diabetic footwear continues to gain market share at an astounding 36.2% market share in 2023.
- Distribution Channel Analysis: Online distribution channels continue to dominate the Diabetic Footwear Market, holding an estimated 55.6% market share.
- Regional Analysis: North America holds a significant market share for diabetic footwear sales in 2023 with 39.8% being held by North America alone.
Product Analysis
Diabetic footwear continues to gain market share at an astounding 36.2% market share. Diabetic-specific shoes have been carefully created with these features in mind: extra depth, wider toe boxes and seamless interiors to help prevent ulcers or other foot complications caused by friction between toes or toe boxes rubbing against each other and seams between interiors preventing irritation that could lead to ulcers forming over time. Diabetics choose shoes because of both style and functionality that offer support without sacrificing aesthetics.
Slippers and sandals have quickly emerged as major contenders in the diabetic footwear market, outshone by shoes alone. Recognizing the varied lifestyles and preferences of diabetic individuals, manufacturers have designed slippers with diabetic-specific features like soft uppers with non-binding closures for customized fits; cushioned insoles; adjustable closures to customize fit accordingly, plus soft non-binding uppers to support any foot shape; customizable closures provide customized closure options allowing a custom fit; these offerings cater towards individuals looking for supportive indoor and outdoor options thereby expanding access as well as inclusivity of diabetic footwear solutions solutions further expanding accessibility acclusion within diabetic footwear solutions themselves.
Distribution Channel Analysis
Online distribution channels continue to dominate the Diabetic Footwear Market, holding an estimated 55.6% market share. Traditional brick-and-mortar stores provide personalized shopping experiences where customers can try on shoes while receiving expert guidance from trained staff members – something which is especially essential for individuals with specific foot health requirements.
Online channels are becoming more and more prominent in the diabetic footwear sector, offering convenience of browsing from home and an array of choices that draw customers in. Furthermore, e-commerce platforms and the ease of information access have contributed to its rise.
Online channels may offer convenience and accessibility; however, their drawbacks such as size concerns and being unable to physically try on shoes remain. With improving services and offerings by online retailers, the diabetic footwear market could see significant expansion through online retailing in the near future. This highlights why manufacturers and retailers need omnichannel strategies in order to adapt with consumer tastes as their preferences shift over time.
Key Market Segments
Product
- Slippers
- Sandals
- Shoes
Distribution Channel
- Offline
- Online
Driver
Increasing Prevalence of Diabetes Globally
The diabetic footwear market is primarily driven by the rising incidence of diabetes worldwide. According to the World Health Organization (WHO), the global prevalence of diabetes among adults over 18 years of age has risen from 4.7% in 1980 to 8.5% in 2014. This significant increase has led to a heightened demand for diabetic footwear, designed to mitigate the risk of foot-related complications, such as ulcers and neuropathy, which are common among diabetic patients.
Diabetic footwear, with its unique design features including non-binding uppers, deep toe-boxes, and seamless interiors, aims to reduce pressure points and enhance comfort, thereby preventing foot injuries. The growing awareness among the diabetic population about the importance of foot care and the availability of customized footwear options are further propelling the market growth.
Trend
Technological Advancements in Diabetic Footwear
The diabetic footwear market is witnessing a notable trend of technological advancements aimed at enhancing the efficacy and comfort of these shoes. Manufacturers are integrating smart technologies such as pressure sensors and Bluetooth connectivity to monitor pressure distribution and foot health in real-time. For instance, the incorporation of microfiber technologies for better moisture-wicking and anti-microbial properties is gaining traction.
These innovations not only offer improved protection against foot complications but also empower users with data to manage their condition more effectively. The adoption of 3D printing technology for custom-made diabetic shoes is another emerging trend, enabling a personalized fit and better accommodation of foot deformities, further fueling the market growth.
Restraint
High Cost and Lack of Awareness
One of the primary restraints facing the diabetic footwear market is the high cost associated with these specialized products. The advanced materials and technology involved in manufacturing diabetic footwear result in higher prices, which can be prohibitive for a significant portion of the diabetic population, especially in developing countries.
Additionally, there is a lack of awareness among patients regarding the importance of diabetic-specific footwear in preventing foot complications. Many individuals continue to wear standard shoes, unaware of the potential risks and the benefits of diabetic footwear. This lack of awareness and the perceived high cost are significant barriers to market penetration, particularly in underserved regions.
Opportunity
Expanding Markets in Developing Countries
The expanding diabetic population in developing countries presents a significant opportunity for the diabetic footwear market. With urbanization and lifestyle changes, countries such as India, China, and Brazil are experiencing a rapid increase in diabetes prevalence. These regions offer untapped markets with a growing middle-class population able to afford specialized healthcare products, including diabetic footwear.
The rising healthcare expenditure and increasing awareness campaigns by governments and NGOs about diabetes care are also aiding market expansion. Collaborations between diabetic footwear manufacturers and healthcare providers for distribution and promotion, coupled with customized and affordable product offerings, can further harness this opportunity for market growth in developing countries.
Regional Analysis
North America holds a significant market share for diabetic footwear sales in 2023 with 39.8% being held by North America alone. This demand can be directly attributed to diabetes prevalence; individuals living with the condition often struggle with nerve damage and poor blood circulation that results in foot ulcers or, in severe cases, even limb amputation. Therefore many consumers actively search for diabetic footwear as a preventive measure against such complications.
Canada has witnessed impressive growth in diabetic footwear sales due to technological innovations and an aging population susceptible to diabetes, as reported in Statistics Canada’s 2022 report. Statistics Canada indicated that approximately 27.7% of individuals aged 50 or above in Canada are living with the condition; furthermore, government support such as CARMEN Initiative, Be He@lthy Be Mobile initiative, Cuban Plan for Diabetes Education have all played important roles in creating greater awareness around risks and complications related to diabetes – leading to an ever increasing demand for diabetic footwear throughout Canada and Cuban Plan for Diabetes Education have played pivotal roles in raising awareness surrounding risks related to this condition – contributing further increasing demand within this region.
Key Regions and Countries
North America
- The US
- Canada
- Mexico
Western Europe
- Germany
- France
- The UK
- Spain
- Italy
- Portugal
- Ireland
- Austria
- Switzerland
- Benelux
- Nordic
- Rest of Western Europe
Eastern Europe
- Russia
- Poland
- The Czech Republic
- Greece
- Rest of Eastern Europe
APAC
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- Indonesia
- Malaysia
- Philippines
- Singapore
- Thailand
- Vietnam
- Rest of APAC
Latin America
- Brazil
- Colombia
- Chile
- Argentina
- Costa Rica
- Rest of Latin America
Middle East & Africa
- Algeria
- Egypt
- Israel
- Kuwait
- Nigeria
- Saudi Arabia
- South Africa
- Turkey
- United Arab Emirates
- Rest of MEA
Market Player Analysis
The competitive landscape of the diabetic footwear market offers comprehensive insights into each competitor. These details encompass company profiles, financial performance, revenue figures, market potential, investments in research and development, new market ventures, global reach, production facilities, capacity, strengths and weaknesses, product launches, product range, and application dominance. The aforementioned data points exclusively pertain to the companies’ activities within the diabetic footwear market segment.
Key Player Analysis
- Podartis Srl
- Aetrex Worldwide
- DJO Global Inc.
- Dr. Zen Products, Inc.
- Orthofeet Inc
- Other Key Players
Recent Developments
- Podartis Srl: Focuses on diabetic footwear with pressure relief properties and customisable features to improve wearability and prevent foot ulcers.
- Aetrex Worldwide: Recently expanded their global presence through partnerships with distributors in new markets.
- DJO Global Inc.: DJO continues to invest in research and development of new technologies for diabetic foot care.
- Orthofeet Inc.: Recently launch of their new cloud-based fitting system for a more personalized experience.
Report Scope
Report Features Description Market Value (2023) USD 8.5 Billion Forecast Revenue (2033) USD 18.2 Billion CAGR (2024-2033) 7.9% Base Year for Estimation 2023 Historic Period 2018-2022 Forecast Period 2024-2033 Report Coverage Revenue Forecast, Market Dynamics, Competitive Landscape, Recent Developments Segments Covered By Product (Slippers, Sandals, Shoes) By Distribution Channel (Offline, Online) Regional Analysis North America-US, Canada, Mexico;Europe-Germany, UK, France, Italy, Russia, Spain, Rest of Europe;APAC-China, Japan, South Korea, India, Rest of Asia-Pacific;South America-Brazil, Argentina, Rest of South America;MEA-GCC, South Africa, Israel, Rest of MEA Competitive Landscape Podartis Srl, Aetrex Worldwide, DJO Global Inc., Dr. Zen Products, Inc., Orthofeet Inc, Other Key Players Customization Scope Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements. Purchase Options We have three licenses to opt for: Single User License, Multi-User License (Up to 5 Users), Corporate Use License (Unlimited User and Printable PDF) Frequently Asked Questions (FAQ)
What is diabetic footwear?Diabetic footwear is specially designed footwear for individuals with diabetes to reduce the risk of foot complications.
What are the benefits of diabetic footwear?Diabetic footwear provides comfort, protection, and support to prevent foot ulcers and other diabetic-related problems. It also minimizes the risk of foot injuries and promotes overall foot health.
How big is the Diabetic Footwear Market?The global Diabetic Footwear Market size was estimated at USD 8.5 Billion in 2023 and is expected to reach USD 18.2 Billion in 2033.
What is the Diabetic Footwear Market growth?The global Diabetic Footwear Market is expected to grow at a compound annual growth rate of 7.9%. From 2024 To 2033
Who are the key companies/players in the Diabetic Footwear Market?Some of the key players in the Diabetic Footwear Markets are Podartis Srl, Aetrex Worldwide, DJO Global Inc., Dr. Zen Products, Inc., Orthofeet Inc, Other Key Players.
What drives the demand for diabetic footwear?The increasing prevalence of diabetes worldwide, coupled with rising awareness about foot care among diabetic patients, drives the demand for diabetic footwear.
How is the diabetic footwear market expected to grow?With a growing diabetic population globally and the rising preference for specialized footwear, the diabetic footwear market is projected to experience significant growth in the coming years.
Are there different types of diabetic footwear available?Yes, diabetic footwear comes in various styles and designs to cater to different preferences and needs, including athletic diabetic shoes for active individuals.
- Podartis Srl
- Aetrex Worldwide
- DJO Global Inc.
- Dr. Zen Products, Inc.
- Orthofeet Inc
- Other Key Players
- settingsSettings
Our Clients
Single User $6,000 $3,999 USD / per unit save 24% | Multi User $8,000 $5,999 USD / per unit save 28% | Corporate User $10,000 $6,999 USD / per unit save 32% | |
---|---|---|---|
e-Access | |||
Report Library Access | |||
Data Set (Excel) | |||
Company Profile Library Access | |||
Interactive Dashboard | |||
Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
Accessibility | 1 User | 2-5 User | Unlimited |
Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
Buy Now ($ 3,999) | Buy Now ($ 5,999) | Buy Now ($ 6,999) |